GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy
Clinical trial NCT00688701 · COMPLETED
Trial details
- NCT number
- NCT00688701
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2009-12-01
- Enrollment
- 361
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.